Cellular therapy for the inner ear
Cellular therapy for the inner ear
批准号:
7258349
负责人:
Albert Edge
金额:
$28.64万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-08-12 至 2008-07-31
关键词:
AcuteAddressAdultAfferent NeuronsAgeAnimal ModelBiological AssayBiological ModelsBrainBungarotoxinsCandidate Disease GeneCell Differentiation processCell LineCell TherapyCellsCharacteristicsChromosome PairingCochleaCochlear nucleusConditionCoupledDevelopmentEarEngraftmentEnvironmentEtiologyFamilyGene ExpressionGene SilencingGeneticGerbilsGoalsGrowth FactorGrowth Factor OverexpressionHair CellsHistologicImmunohistochemistryIn VitroLabyrinthLigandsLuciferasesMeasuresMusNatural regenerationNatureNerveNervous system structureNeurodegenerative DisordersNeuronsNeuropilin-1NeuropilinsNumbersOrgan of CortiOuabainParkinson DiseasePathway interactionsProcessRecovery of FunctionReporterRoleSensorineural Hearing LossSensorySeriesSignal PathwaySmall Interfering RNASourceSpinal GangliaStagingStem cellsSynapsesSystemTestingTherapeuticTimeTissuesTransplantationUndifferentiatedWithdrawalWorkaxonal guidancecell typedesigndesireembryonic stem cellfetalganglion cellin vitro Modelin vivoin vivo Modelinner ear diseasesnerve stem cellnerve supplyneuron lossneuronal guidanceprogenitorpromoterreceptorreconstitutionreinnervationrelating to nervous systemresearch studyresponsesoundspiral ganglionsuccesssynaptogenesistranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Loss of cochlear neurons and hair cells is a major cause of sensorineural hearing loss. One approach to potential treatments is the transplantation of exogenous progenitor cells. Our strategy for developing cell based therapies for inner ear disorders is to study the reinnervation of a de-afferented organ of Corti. We take this approach because 1) only a single cell type, the spiral ganglion cell, must be replaced to see functional recovery; 2) partial regeneration of damaged tissue by cell replacement has been successful in animal models of other neurodegenerative diseases, such as Parkinson's, suggesting that neuronal circuits in the adult nervous system can be reconstituted if appropriate progenitor cells are introduced and 3) understanding the mechanisms underlying re-formation of neural connections to hair cells in the adult ear is important to any therapeutic approach to sensorineural hearing loss. The Specific Aims comprise four inter-related experiments to probe key variables likely to influence the success of hair cell reinnervation by transplanted neural progenitor cells. In Aim 1 the developmental expression by spiral ganglion neurons of several families of neuronal guidance molecules will be studied by immunohistochemistry. In Aim 2 we use de-afferented cochlear explants to study the reinnervation of hair cells by grafted progenitors, in vitro, by modifying characteristics of the donor cells (e.g. silencing expression of selected guidance molecules or controlling degree of differentiation) or the host environment (e.g. developmental age of the explant or etiology of the initial de-afferentation). In Aim 3 we build on the in vitro results to choose donor cells for in vivo transplantation into a chemically de-afferented gerbil ear, in which the sensory cells are intact but spiral ganglion cells are destroyed. In this model system, success of reinnervation can be assayed both functionally and histologically. In Aim 4 we use a reporter assay to determine conditions needed to bias differentiation of stem cells to a lineage corresponding to sensory neurons by adding specific growth factors in a timed sequence, and by over expressing transcription factors in the pathway to sensory neurons. Clonal cell lines isolated under this Aim will serve as additional donor cell types to be studied in Aims 3 and 4.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Determination of Hair Cell Fate from Postnatal Cochlear Supporting Cells
-
批准号:10617788
-
项目类别:
-
资助金额:$61.74万
-
财政年份:2022
-
负责人:Albert Edge
-
依托单位:
Determination of Hair Cell Fate from Postnatal Cochlear Supporting Cells
-
批准号:10435013
-
项目类别:
-
资助金额:$61.74万
-
财政年份:2022
-
负责人:Albert Edge
-
依托单位:
Wnt Signaling in Hair Cell Generation from Supporting Cells
-
批准号:9056678
-
项目类别:
-
资助金额:$35.49万
-
财政年份:2015
-
负责人:Albert Edge
-
依托单位:
A cell-specific inducible model of hearing loss
-
批准号:7774210
-
项目类别:
-
资助金额:$23.18万
-
财政年份:2009
-
负责人:Albert Edge
-
依托单位:
A cell-specific inducible model of hearing loss
-
批准号:8004060
-
项目类别:
-
资助金额:$19.0万
-
财政年份:2009
-
负责人:Albert Edge
-
依托单位:
Cellular therapy for the inner ear
-
批准号:7901281
-
项目类别:
-
资助金额:$9.71万
-
财政年份:2009
-
负责人:Albert Edge
-
依托单位:
Cellular therapy for the inner ear
-
批准号:8432824
-
项目类别:
-
资助金额:$39.01万
-
财政年份:2005
-
负责人:Albert Edge
-
依托单位:
Cellular therapy for the inner ear
-
批准号:8233927
-
项目类别:
-
资助金额:$41.06万
-
财政年份:2005
-
负责人:Albert Edge
-
依托单位:
Cellular therapy for the inner ear
-
批准号:8984514
-
项目类别:
-
资助金额:$49.24万
-
财政年份:2005
-
负责人:Albert Edge
-
依托单位:
Cellular therapy for the inner ear
-
批准号:7791386
-
项目类别:
-
资助金额:$41.02万
-
财政年份:2005
-
负责人:Albert Edge
-
依托单位:
Cellular therapy for the inner ear
-
批准号:6970446
-
项目类别:
-
资助金额:$30.2万
-
财政年份:2005
-
负责人:Albert Edge
-
依托单位:
Cellular therapy for the inner ear
-
批准号:7110259
-
项目类别:
-
资助金额:$29.49万
-
财政年份:2005
-
负责人:Albert Edge
-
依托单位:
Cellular therapy for the inner ear
-
批准号:9115132
-
项目类别:
-
资助金额:$56.78万
-
财政年份:2005
-
负责人:Albert Edge
-
依托单位:
Cellular therapy for the inner ear
-
批准号:8036967
-
项目类别:
-
资助金额:$41.06万
-
财政年份:2005
-
负责人:Albert Edge
-
依托单位:
Cellular therapy for the inner ear
-
批准号:9322526
-
项目类别:
-
资助金额:$56.78万
-
财政年份:2005
-
负责人:Albert Edge
-
依托单位:
Cellular therapy for the inner ear
-
批准号:7652917
-
项目类别:
-
资助金额:$39.45万
-
财政年份:2005
-
负责人:Albert Edge
-
依托单位:
Conversion of stem cells to cell types of the inner ear
-
批准号:6877059
-
项目类别:
-
资助金额:$3.03万
-
财政年份:2004
-
负责人:Albert Edge
-
依托单位:
Conversion of stem cells to cell types of the inner ear
-
批准号:6792817
-
项目类别:
-
资助金额:$6.05万
-
财政年份:2004
-
负责人:Albert Edge
-
依托单位:
HEPATOCELLULAR THERAPY FOR HYPERCHOLESTEROLEMIA
-
批准号:2148977
-
项目类别:
-
资助金额:$8.1万
-
财政年份:1994
-
负责人:Albert Edge
-
依托单位:
CARBOHYDRATE OF THE INSULIN RECEPTOR
-
批准号:3237794
-
项目类别:
-
资助金额:$8.53万
-
财政年份:1987
-
负责人:Albert Edge
-
依托单位:
海外基金